Publication | Open Access

Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease

HypertensionUrologyChronic Renal DiseaseAntiproteinuric EffectCardiovascular DiseaseHypertensive PatientsMedicineAntihypertensive TherapyChronic Kidney DiseaseRenal FunctionPharmacotherapyPharmacologyNephrology